Abstract
To elucidate the role of iron in the pathomechanisms of autoimmune CNS disorders, we estimated the tissue concentrations of Fe2+ in the brain, spinal cord, and liver in the chronic relapsing form of experimental autoimmune encephalomyelitis (EAE). The disease was induced in Dark Agouti (DA) strain of rats, by subcutaneous injection of bovine brain homogenate in complete Freund's adjuvant (CFA). Control rats consisted of unsensitized rats and of rats treated with CFA or saline. The data obtained by clinical assessment and by inductively coupled plasma spectrometry have shown that the attacks of disease (on the 12th and 22nd post-immunization day) were followed by high accumulation of iron in the liver. Additionally, during the second attack of disease, the decreased concentration of Fe2+ was found in cervical spinal cord. The data point to regulatory effects of iron and hepatic trace elements regulating mechanisms in the pathogenesis of EAE.
Similar content being viewed by others
References
Connor JR, Menzies SL (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17:83–93
Levine SM, Chakrabarty A (2004) The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann NY Acad Sci 1012:252–266
Moos T (2002) Brain iron homeostasis. Dan Med Bull 49:279–301
Connor JR, Menzies SL, Burdo JR et al (2001) Iron and iron management proteins in neurobiology. Pediatr Neurol 25:118–129
Todorich B, Pasquini JM, Garcia CI et al (2009) Oligodendrocytes and myelination: the role of iron. Glia 57:467–478
Moos T, Rosengren Nielsen T (2006) Ferroportin in the postnatal rat brain: implications for axonal transport and neuronal export of iron. Semin Pediatr Neurol 13:149–157
Simmons DA, Casale M, Alcon B et al (2007) Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease. Glia 55:1074–1084
Barnham KJ, Bush AI (2008) Metals in Alzheimer's and Parkinson's diseases. Curr Opin Chem Biol 12:222–228
Brewer GJ (2010) Risks of copper and iron toxicity during aging in humans. Chem Res Toxicol 123:319–326
Stankiewicz J, Panter SS, Neema M et al (2007) Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 4:371–386
Connor JR, Pavlick G, Karli D et al (1995) A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol 355:111–123
LeVine SM (1997) Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 760:298–303
Smith KJ, Kapoor R, Felts PA (1999) Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 9:69–92
Forge JK, Pedchenko TV, LeVine SM (1998) Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. Life Sci 63:2271–2284
Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119–145
Pedersen MO, Jensen R, Pedersen DS et al (2009) Metallothionein-I + II in neuroprotection. Biofactors 35:315–325
Ekdahl CT, Kokaia Z, Lindvall O (2009) Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158:1021–1029
Grant SM, Wiesinger JA, Beard JL et al (2003) Iron-deficient mice fail to develop autoimmune encephalomyelitis. J Nutr 133:2635–2638
Haacke EM, Makki M, Ge Y et al (2009) Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 29:537–544
Haacke EM, Cheng NY, House MJ et al (2005) Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 23:1–25
Jakovac H, Grebić D, Tota M et al (2010) Time-course expression of metallothioneins and tissue metals in chronic relapsing form of experimental autoimmune encephalomyelitis. Histol Histopathol (in press)
Vukmanovic S, Mostarica Stojkovic M, Lukic ML (1989) Experimental autoimmune encephalomyelitis in “low” and “high” interleukin 2 producer rats. I. Cellular basis of induction. Cell Immunol 121:237–246
Muhvic D, Radosevic-Stasic B, Pugel E et al (1992) Modulation of experimental allergic encephalomyelitis by somatostatin. Ann NY Acad Sci 650:170–178
Jakovac H, Grebic D, Mrakovcic-Sutic I et al (2006) Metallothionein expression and tissue metal kinetics after partial hepatectomy in mice. Biol Trace Elem Res 114:249–268
Mannie M, Swanborg RH, Stepaniak JA (2009) Experimental autoimmune encephalomyelitis in the rat. Curr Protoc Immunol Chapter 15:Unit 15 2
Lehmann HC, Meyer zu Horste G, Kieseier BC et al (2009) Review: pathogenesis and treatment of immune-mediated neuropathies. Ther Adv Neurol Disord 2:261–281
Bhat R, Axtell R, Mitra A et al (2010) Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci USA 107:2580–2585
Bhat R, Steinman L (2009) Innate and adaptive autoimmunity directed to the central nervous system. Neuron 64:123–132
Platten M, Youssef S, Hur EM et al (2009) Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA 106:14948–14953
Becher B, Bechmann I, Greter M (2006) Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain. J Mol Med 84:532–543
West AK, Chuah MI, Vickers JC et al (2004) Protective role of metallothioneins in the injured mammalian brain. Rev Neurosci 15:157–166
Schonberg DL, McTigue DM (2009) Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol 218:64–74
Weiss G (2002) Iron and immunity: a double-edged sword. Eur J Clin Investig 32(Suppl 1):70–78
Kell DB (2009) Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2:2
Linker RA, Kroner A, Horn T et al (2006) Iron particle-enhanced visualization of inflammatory central nervous system lesions by high resolution: preliminary data in an animal model. AJNR Am J Neuroradiol 27:1225–1229
Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685–716
Koj A (1996) Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta (BBA)—Mol Basis Dis 1317:84–94
Vyoral D, Hepcidin PJ (2005) A direct link between iron metabolism and immunity. Int J Biochem Cell Biol 37:1768–1773
Loreal O, Haziza-Pigeon C, Troadec MB et al (2005) Hepcidin in iron metabolism. Curr Protein Pept Sci 6:279–291
Ganz T (2005) Hepcidin—a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 18:171–182
Moffatt P, Denizeau F (1997) Metallothionein in physiological and physiopathological processes. Drug Metab Rev 29:261–307
Coyle P, Philcox JC, Carey LC et al (2002) Metallothionein: the multipurpose protein. Cell Mol Life Sci 59:627–647
Kozlowski H, Janicka-Klos A, Brasun J et al (2009) Copper, iron, and zinc ions homeostasis and their role in neurodegenerative disorders (metal uptake, transport, distribution and regulation). Coord Chem Rev 253:2665–2685
Verga Falzacappa MV, Vujic Spasic M, Kessler R et al (2007) STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109:353–358
Muckenthaler MU, Galy B, Hentze MW (2008) Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu Rev Nutr 28:197–213
Nemeth E, Ganz T (2006) Regulation of iron metabolism by hepcidin. Annu Rev Nutr 26:323–342
Balesaria S, Ramesh B, McArdle H et al (2009) Divalent metal-dependent regulation of hepcidin expression by MTF-1. FEBS Lett 584:719–725
Nemeth E, Valore EV, Territo M et al (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461–2463
Latunde-Dada GO (2009) Iron metabolism: microbes, mouse, and man. Bioessays 31:1309–1317
Penkowa M, Caceres M, Borup R et al (2006) Novel roles for metallothionein-I + II (MT-I + II) in defense responses, neurogenesis, and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wild-type and MT-I + II knockout mice. J Neurosci Res 84:1452–1474
West AK, Hidalgo J, Eddins D et al (2008) Metallothionein in the central nervous system: roles in protection, regeneration and cognition. NeuroToxicol 29:489–503
Mocchegiani E, Giacconi R, Muzzioli M et al (2002) Altered zinc binding by metallothioneins in immune-neuroendocrine senescence: a vicious circle between metallothioneins and chaperones? Adv Cell Aging Gerontol 13:261–281
Thirumoorthy N, Manisenthil Kumar KT, Shyam Sundar A et al (2007) Metallothionein: an overview. World J Gastroenterol 13:993–996
Mocchegiani E, Giacconi R, Cipriano C et al (2009) NK and NKT cells in aging and longevity: role of zinc and metallothioneins. J Clin Immunol 29:416–425
Mocchegiani E, Giacconi R, Muti E et al (2004) Zinc, immune plasticity, aging, and successful aging: role of metallothionein. Ann NY Acad Sci 1019:127–134
Rink L, Haase H (2007) Zinc homeostasis and immunity. Trends Immunol 28:1–4
Prasad A (2007) Zinc: mechanisms of host defense. J Nutr 137:1345–1349
Sawa Y, Arima Y, Ogura H et al (2009) Hepatic interleukin-7 expression regulates T cell responses. Immunity 30:447–457
Abo T, Kawamura T, Watanabe H (2000) Physiological responses of extrathymic T cells in the liver. Immunol Rev 174:135–149
Crispe IN (2009) The liver as a lymphoid organ. Annu Rev Immunol 27:147–163
Acknowledgement
This work was supported by a grant from the Croatian Ministry of Science (Projects Nos 62-0621341-1337 and 62-0621341-0061).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by grants 0621341-0061 and 0621341-1337 from Croatian Ministry of Science.
Rights and permissions
About this article
Cite this article
Tota, M., Jakovac, H., Grebić, D. et al. Kinetics of Tissue Iron in Experimental Autoimmune Encephalomyelitis in Rats. Biol Trace Elem Res 143, 332–343 (2011). https://doi.org/10.1007/s12011-010-8841-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-010-8841-8